Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-May-24 7:17 AM View:  | BioCryst Pharmaceuticals Inc. (BCRX) | 14-May-24 | Private Purchase | 30,000 | $5.86 | $175,800.00 | 12% 242.14K to 272.14K | |
| 02-Apr-24 4:21 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Mar-24 | Payment of Exercise | 7,525 | $5.08 | $38,227.00 | (3%) 249.66K to 242.14K | |
| 12-Feb-24 4:47 PM View: | Immunogen Inc. (IMGN) | 12-Feb-24 | Disposition | 3,074 | -- | -- | (100%) 3.07K to 0 | |
| 03-Jan-24 5:42 PM View: | Immunogen Inc. (IMGN) | 29-Dec-23 | Grant | 252 | $29.65 | $7,471.80 | 9% 2.82K to 3.07K | |
| 20-Dec-23 4:42 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 5,580 | $6.05 | $33,759.00 | (2%) 255.24K to 249.66K | |
| 18-Dec-23 4:47 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 51,000 | -- | -- | 25% 207.28K to 258.27K | |
| 18-Dec-23 4:47 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 3,031 | $6.43 | $19,489.30 | (1%) 258.27K to 255.24K | |
| 02-Oct-23 10:00 PM View: | Immunogen Inc. (IMGN) | 29-Sep-23 | Grant | 472 | $15.87 | $7,490.64 | 20% 2.35K to 2.82K | |
| 05-Jul-23 5:52 PM View: | Immunogen Inc. (IMGN) | 30-Jun-23 | Grant | 397 | $18.87 | $7,491.39 | 20% 1.95K to 2.35K | |
| 05-Apr-23 4:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Apr-23 | Sale (Planned) | 7,000 | $8.29 | $58,030.00 | (3%) 214.28K to 207.28K | |
| 04-Apr-23 4:54 PM View: | Immunogen Inc. (IMGN) | 31-Mar-23 | Grant | 1,953 | $3.84 | $7,499.52 | 100% 0 to 1.95K | |
| 21-Dec-22 4:41 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-22 | Grant | 81,000 | -- | -- | 61% 133.28K to 214.28K | |
| 19-Dec-22 4:58 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Dec-22 | Sale | 3,125 | $10.89 | $34,031.20 | (2%) 136.4K to 133.28K | |
| 04-Apr-22 4:32 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Apr-22 | Private Sale | 7,600 | $16.20 | $123,120.00 | (5%) 144.0K to 136.4K | |
| 16-Dec-21 5:06 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-21 | Grant | 44,000 | -- | -- | 44% 100.0K to 144.0K | |
| 02-Apr-21 5:26 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Mar-21 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 22-Jan-21 4:05 PM View: | Glycomimetics Inc (GLYC) | 20-Jan-21 | Grant | 34,500 | -- | -- | 23% 148.62K to 183.12K | |
| 12-Dec-17 4:14 PM View: | Glycomimetics Inc (GLYC) | 08-Dec-17 | Market Sale | 2,000 | $15.01 | $30,020.00 | (1%) 150.62K to 148.62K | 83% |
| 18-Sep-17 6:15 PM View: | Glycomimetics Inc (GLYC) | 18-Sep-17 | Market Sale | 2,000 | $13.00 | $26,000.00 | (1%) 152.62K to 150.62K | 80% |
| 30-May-17 4:07 PM View: | Glycomimetics Inc (GLYC) | 25-May-17 | Market Sale | 2,000 | $15.57 | $31,140.00 | (1%) 154.62K to 152.62K | 84% |
| 22-May-17 9:23 PM View: | Glycomimetics Inc (GLYC) | 19-May-17 | Market Sale (Planned) | 2,000 | $12.14 | $24,280.00 | (1%) 156.62K to 154.62K | 79% |
| 04-Oct-16 4:22 PM View: | Glycomimetics Inc (GLYC) | 03-Oct-16 | Market Sale (Planned) | 4,000 | $7.00 | $28,001.00 | (2%) 160.62K to 156.62K | 62% |
| 21-Jul-16 5:27 PM View: | Glycomimetics Inc (GLYC) | 20-Jul-16 | Market Sale (Planned) | 2,000 | $8.00 | $16,000.00 | (1%) 162.62K to 160.62K | 67% |
| 06-Jul-16 5:07 PM View: | Glycomimetics Inc (GLYC) | 06-Jul-16 | Market Sale (Planned) | 6,796 | $6.68 | $45,397.30 | (4%) 169.41K to 162.62K | 60% |
| 06-Jul-16 5:07 PM View: | Glycomimetics Inc (GLYC) | 05-Jul-16 | Market Sale (Planned) | 10,136 | $7.01 | $71,053.40 | (6%) 179.55K to 169.41K | 62% |
| 06-Jul-16 5:07 PM View: | Glycomimetics Inc (GLYC) | 01-Jul-16 | Market Sale (Planned) | 5,068 | $7.40 | $37,503.20 | (3%) 184.62K to 179.55K | 64% |